Armata Pharmaceuticals In... (ARMP)
AMEX: ARMP
· Real-Time Price · USD
2.55
0.02 (0.79%)
At close: Aug 15, 2025, 3:56 PM
2.34
-8.24%
After-hours: Aug 15, 2025, 06:13 PM EDT
Armata Pharmaceuticals Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -25.71M | -426K | -18.92M | -41.36M | -67.04M | -79.58M | -69.05M | -59.51M | -36.97M | -42.63M | -36.92M | -32.65M | -29.45M | -26.43M | -23.16M | -23.73M | -24.08M | -22.6M |
Depreciation & Amortization | 1.44M | 1.39M | 1.32M | 1.24M | 1.15M | 1.06M | 972K | 924K | 929K | 896K | 892K | 924K | 1.01M | 1.11M | 1.17M | 1.17M | 1.12M | 1.1M |
Stock-Based Compensation | 2.38M | 3.14M | 2.89M | 2.73M | 1.69M | 615K | 938K | 1.56M | 2.78M | 3.47M | 3.1M | 2.95M | 2.58M | 2.53M | 2.88M | 3.08M | 3.27M | 3.27M |
Other Working Capital | -508K | 1.22M | 1.66M | -1.06M | 515K | -3.9M | -9.69M | -14.78M | -18.1M | -13.75M | -4.17M | -2.94M | 243K | 772K | -3M | -419K | -11K | -936K |
Other Non-Cash Items | -6.75M | -37.04M | -20.75M | 2.81M | 23.91M | 38.03M | 25.91M | 15.24M | -115K | 7.22M | 4.06M | 401K | -1.92M | -3.23M | -3.16M | 231K | 390K | 531K |
Deferred Income Tax | n/a | n/a | n/a | -419K | 3.44M | 3.44M | 3.44M | 3.42M | -2.76M | -4.06M | -4.06M | -401K | 1.2M | 2.5M | 1.92M | -1.74M | -1.02M | -1.02M |
Change in Working Capital | -2.94M | -1.6M | -2.1M | -2.73M | -1.7M | -4.01M | -9.65M | -11.44M | -14.32M | -11.43M | 439K | -1.82M | 1.37M | 1.9M | -3.22M | -284K | 124K | -801K |
Operating Cash Flow | -31.58M | -34.55M | -37.55M | -37.73M | -38.55M | -40.44M | -47.42M | -49.8M | -50.45M | -46.54M | -32.48M | -30.59M | -25.23M | -21.61M | -23.57M | -21.28M | -20.2M | -19.51M |
Capital Expenditures | -511K | -1.73M | -1.88M | -4.36M | -7.53M | -6.38M | -8.14M | -5.29M | -3.07M | -3.98M | -2.21M | -2.89M | -2.18M | -1.24M | -1.3M | -1.44M | -941K | -1.02M |
Cash Acquisitions | n/a | n/a | n/a | 10K | 10K | 10K | 10K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | -511K | -1.73M | -1.88M | -4.35M | -7.52M | -6.37M | -8.13M | -5.29M | -3.07M | -3.98M | -2.21M | -2.89M | -2.18M | -1.24M | -1.3M | -1.44M | -941K | -1.02M |
Debt Repayment | -24.89M | -24.89M | n/a | 34.89M | 59.69M | 59.32M | 54.03M | 54.03M | 29.23M | 29.59M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | -14K | -14K | n/a | -43K | -43K | -43K | -43K | n/a | n/a | -146K | -146K | -146K | -146K | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 34.89M | 34.89M | 34.89M | n/a | n/a | n/a | n/a | -500K | -469K | -469K | -469K | 113K | 168K | 168K | -801K | -451K | -477K | 241K |
Financial Cash Flow | 9.93M | 10.01M | 34.96M | 34.91M | 59.78M | 59.33M | 53.99M | 53.53M | 28.76M | 28.98M | 44.02M | 51.55M | 51.61M | 51.57M | 25.52M | 18.91M | 18.89M | 19.38M |
Net Cash Flow | -22.17M | -26.26M | -4.47M | -7.06M | 13.81M | 12.62M | -1.47M | -1.56M | -24.76M | -21.54M | 9.32M | 18.07M | 24.2M | 28.71M | 639K | -3.81M | -2.25M | -1.15M |
Free Cash Flow | -32.09M | -36.27M | -39.43M | -42.09M | -46.08M | -46.82M | -55.57M | -55.09M | -53.52M | -50.52M | -34.69M | -33.49M | -27.41M | -22.86M | -24.88M | -22.72M | -21.14M | -20.53M |